{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:47:47Z","timestamp":1793407667012,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003065","name":"Universit\u00e4t Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bioorg.2026.109932","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T14:43:04Z","timestamp":1777732984000},"page":"109932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Synthesis, in silico and in vitro evaluation of N-phenylbenzimidazole derivatives targeting muscarinic acetylcholine receptors"],"prefix":"10.1016","volume":"178","author":[{"given":"Marlon","family":"Millard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Dzedulionyt\u0117 M\u00fcld\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Kilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Mair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Holzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Ozenil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109932_bb0005","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrd4295","article-title":"Muscarinic acetylcholine receptors: novel opportunities for drug development","volume":"13","author":"Kruse","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.109932_bb0010","first-page":"369","article-title":"A new era of muscarinic acetylcholine receptor modulators in neurological diseases","volume":"18","author":"Tsimpili","year":"2025","journal-title":"Cancer Drug Abuse. Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.109932_bb0015","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41573-024-01007-1","article-title":"A golden age of muscarinic acetylcholine receptor modulation in neurological diseases","volume":"23","author":"Tobin","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.109932_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/braincomms\/fcaa058","article-title":"M1 muscarinic acetylcholine receptor dysfunction in moderate Alzheimer\u2019s disease pathology","volume":"2","author":"Yi","year":"2020","journal-title":"Brain Commun."},{"key":"10.1016\/j.bioorg.2026.109932_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0141493","article-title":"Urinary retention, incontinence, and dysregulation of muscarinic receptors in male mice lacking Mras","volume":"10","author":"Ehrhardt","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2026.109932_bb0030","series-title":"Physiology, Cholinergic Receptors., Treasure Island(FL)","author":"Carlson","year":"2019"},{"key":"10.1016\/j.bioorg.2026.109932_bb0035","series-title":"Neuropsychotherapeutics","first-page":"153","article-title":"Chapter six - selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disorders","volume":"vol. 86","author":"Teal","year":"2019"},{"key":"10.1016\/j.bioorg.2026.109932_bb0040","first-page":"1","article-title":"Loss of muscarinic M5 receptor function manifests disparate impairments in exploratory behavior in male and female mice despite common dopamine regulation","volume":"000421","author":"Razidlo","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.bioorg.2026.109932_bb0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jnr.10728","article-title":"Role for M5 muscarinic acetylcholine receptors in cocaine addiction","volume":"74","author":"Fink-Jensen","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bioorg.2026.109932_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2020.108089","article-title":"Examining the role of muscarinic M5 receptors in VTA cholinergic modulation of depressive-like and anxiety-related behaviors in rats","volume":"171","author":"Nunes","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bioorg.2026.109932_bb0055","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/s41386-017-0007-3","article-title":"Muscarinic M5 receptors modulate ethanol seeking in rats","volume":"43","author":"Berizzi","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bioorg.2026.109932_bb0060","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1111\/bph.15513","article-title":"Muscarinic M4 and M5 receptors in the ventral subiculum differentially modulate alcohol seeking versus consumption in male alcohol-preferring rats","volume":"178","author":"Walker","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109932_bb0065","first-page":"1034702","article-title":"Synthesis and evaluation of fluorinated Peptidomimetics enabling the development of 18 F-Labeled Radioligands targeting muscarinic acetylcholine receptor subtype M3","author":"Herrera-Rueda","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.109932_bb0070","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/ph15020248","article-title":"Design, synthesis, and biological evaluation of 4,4\u2019-Difluorobenzhydrol carbamates as selective M1 antagonists","volume":"15","author":"Kilian","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.109932_bb0075","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.3390\/molecules27103173","article-title":"Synthesis, biological evaluation, and docking studies of antagonistic hydroxylated Arecaidine esters targeting mAChRs","volume":"27","author":"Kilian","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109932_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112623","article-title":"Enhanced arecoline derivatives as muscarinic acetylcholine receptor M1 ligands for potential application as PET radiotracers","volume":"204","author":"Ozenil","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109932_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph13120437","article-title":"Synthesis, biological, and computational evaluation of antagonistic, chiral hydrobenzoin esters of arecaidine targeting machr m1","volume":"13","author":"Ozenil","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.109932_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-02732-y","article-title":"Unexpected scaffold rearrangement product of pirenzepine found in commercial samples","volume":"11","author":"Ozenil","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109932_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fnume.2022.853475","article-title":"The application of in silico methods for prediction of blood-brain barrier permeability of small molecule PET tracers","volume":"2","author":"St\u00e9en","year":"2022","journal-title":"Front. Nuclear Med."},{"key":"10.1016\/j.bioorg.2026.109932_bb0100","first-page":"119","article-title":"Small molecules as radiopharmaceutical vectors Antony. Radiopharmaceutical","author":"Gee","year":"2019","journal-title":"Chemistry"},{"key":"10.1016\/j.bioorg.2026.109932_bb0105","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1021\/acschemneuro.2c00269","article-title":"In silico approaches for addressing challenges in CNS radiopharmaceutical design","volume":"13","author":"Jackson","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2026.109932_bb0110","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature17188","article-title":"Crystal structures of the M1 and M4 muscarinic acetylcholine receptors","volume":"531","author":"Thal","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.109932_bb0115","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10753","article-title":"Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist","volume":"482","author":"Haga","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.109932_bb0120","doi-asserted-by":"crossref","first-page":"26001","DOI":"10.1073\/pnas.1914446116","article-title":"Crystal structure of the M5 muscarinic acetylcholine receptor","volume":"116","author":"Vuckovic","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2026.109932_bb0125","series-title":"Structural insights into the subtype-selective antagonist binding to the M2 muscarinic receptor","first-page":"1150","volume":"14","author":"Suno","year":"2019"},{"key":"10.1016\/j.bioorg.2026.109932_bb0130","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1111\/bph.13504","article-title":"Effects of target binding kinetics on in vivo drug efficacy: koff, konand rebinding","author":"Vauquelin","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109932_bb0135","unstructured":"https:\/\/www.proteinatlas.org\/ n.d."},{"key":"10.1016\/j.bioorg.2026.109932_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115891","article-title":"Design, synthesis and preclinical evaluation of muscarine receptor antagonists via a scaffold-hopping approach","volume":"262","author":"Millard","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109932_bb0145","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/jhet.5570270636","article-title":"The improved convergent syntheses of Arecolones and Isoarecolone","volume":"27","author":"Ward","year":"1990","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2026.109932_bb0150","doi-asserted-by":"crossref","first-page":"26001","DOI":"10.1073\/pnas.1914446116","article-title":"Crystal structure of the M5 muscarinic acetylcholine receptor","volume":"116","author":"Vuckovic","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2026.109932_bb0155","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.109932_bb0160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters","volume":"45","author":"Wolber","year":"2005","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.109932_bb0165","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.tips.2009.05.005","article-title":"PET radiotracers: crossing the blood-brain barrier and surviving metabolism","volume":"30","author":"Pike","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2026.109932_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nucmedbio.2017.03.003","article-title":"LogP, a yesterday\u2019s value?","volume":"50","author":"Vraka","year":"2017","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.bioorg.2026.109932_bb0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0021-9673(02)00064-X","article-title":"Method for measuring the logarithm of the octanol-water partition coefficient by using short octadecyl-poly(vinyl alcohol) high-performance liquid chromatography columns","volume":"952","author":"Donovan","year":"2002","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.bioorg.2026.109932_bb0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.addr.2016.04.029","article-title":"Rule of five in 2015 and beyond: target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions","volume":"101","author":"Lipinski","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2026.109932_bb0185","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"64","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2026.109932_bb0190","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Hassan","year":"2005","journal-title":"NeuroRX"},{"key":"10.1016\/j.bioorg.2026.109932_bb0195","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1021\/acschemneuro.6b00029","article-title":"Central nervous system multiparameter optimization desirability: application in drug discovery","volume":"7","author":"Wager","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2026.109932_bb0200","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2026.109932_bb0205","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1021\/jm400312y","article-title":"Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand","volume":"56","author":"Zhang","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109932_bb0210","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1021\/acs.jmedchem.9b01220","article-title":"The blood\u2013brain barrier (BBB) score","volume":"62","author":"Gupta","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109932_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2019.00255","article-title":"Is there a role for GPCR agonist radiotracers in PET neuroimaging?","volume":"12","author":"Colom","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bioorg.2026.109932_bb0220","first-page":"98","article-title":"Exploring how structural and dynamic properties of bovine and canine serum albumins differ from human serum albumin","author":"Ketrat","year":"2020","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.bioorg.2026.109932_bb0225","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/jm060981b","article-title":"Plasma protein binding affinity and its relationship to molecular structure: an in-silico analysis","volume":"50","author":"Gleeson","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109932_bb0230","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109932_bb0235","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/jlcr.4019","article-title":"Strategies for designing novel positron emission tomography (PET) radiotracers to cross the blood\u2013brain barrier","volume":"66","author":"Lindberg","year":"2023","journal-title":"J Labelled Comp Radiopharm"},{"key":"10.1016\/j.bioorg.2026.109932_bb0240","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1021\/jo01015a529","article-title":"The preparation of 2-Methyl-1-phenylbenzimidazole 3-oxide","volume":"30","author":"Schulenberg","year":"1965","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.109932_bb0245","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1002\/asia.202100972","article-title":"Sustainable synthesis of 2-Hydroxymethylbenzimidazoles using D-fructose as a C2 synthon","volume":"16","author":"Raja","year":"2021","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.bioorg.2026.109932_bb0250","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/adsc.200404193","article-title":"N-arylation of benzimidazole with arylboronate, boroxine and boronic acids. Acceleration with an optimal amount of water","volume":"346","author":"Nishiura","year":"2004","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.bioorg.2026.109932_bb0255","article-title":"Bicyclic benzimidazole compounds and their use as metabotropic glutamate receptor potentiators","author":"Ian","year":"2006","journal-title":"WO2007115077A2"},{"key":"10.1016\/j.bioorg.2026.109932_bb0260","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.bmc.2005.10.060","article-title":"Tricyclic pharmacophore-based molecules as novel integrin \u03b1v\u03b23 antagonists. Part 1: design and synthesis of a lead compound exhibiting \u03b1v\u03b23\/ \u03b1IIb\u03b23 dual antagonistic activity","volume":"14","author":"Kubota","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109932_bb0265","series-title":"Yasuo Sygiyama SM. Heterocyclic compound, its production and pharmaceutical preparation. JPH08295667A","author":"Natsukari","year":"1995"},{"key":"10.1016\/j.bioorg.2026.109932_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130701","article-title":"Azolium mediated N[sbnd]heterocyclic carbene selenium adducts: synthesis, cytotoxicity and molecular docking studies","volume":"1241","author":"Ashraf","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109932_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116352","article-title":"Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity","volume":"46","author":"Ma","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109932_bb0280","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/jlac.19717470117","article-title":"Derivate des Imidazo[4.5-b]- und Imidazo[4.5-c]pyridins","volume":"171","author":"Cleve","year":"1971","journal-title":"Liebigs Ann Chem"},{"key":"10.1016\/j.bioorg.2026.109932_bb0285","doi-asserted-by":"crossref","DOI":"10.1002\/cpph.9","article-title":"In vitro drug metabolism using liver Microsomes","volume":"74","author":"Knights","year":"2016","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109932_bb0290","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/pharmaceutics17020273","article-title":"A sequential ultrafiltration method to enhance the accuracy and throughput in plasma protein binding tests","volume":"17","author":"Jeon","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2026.109932_bb0295","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.xphs.2016.10.006","article-title":"Assessment of the blood-brain barrier permeability of potential neuroprotective Aurones in parallel artificial membrane permeability assay and porcine brain endothelial cell models","volume":"106","author":"Liew","year":"2017","journal-title":"J. Pharm. Sci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T08:47:52Z","timestamp":1779698872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826004682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":59,"alternative-id":["S0045206826004682"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109932","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, in silico and in vitro evaluation of N-phenylbenzimidazole derivatives targeting muscarinic acetylcholine receptors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109932","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109932"}}